Unbound MEDLINE

Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). [Qual Life Res] Journal article

 
TitleHealth-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8).
Author(s)Protopopescu C, Marcellin F, Spire B, Préau M, Verdon R, Peyramond D, Raffi F, Chêne G, Leport C, Carrieri MP 
InstitutionHealth and Medical Research National Institute (INSERM), Research Unit 379, Social Sciences Applied to Medical Innovation, 23, rue Stanislas Torrents, 13006, Marseilles, France.
SourceQual Life Res 2007 Feb 1.
AbstractBACKGROUND: The long-term efficacy of Highly Active Antiretroviral Therapies (HAART) has enlightened the crucial role of health-related quality of life (HRQL) among HIV-infected patients. However, any analysis of such extensive longitudinal data necessitates a suitable handling of dropout which may correlate with patients' health status.
METHODS: We analysed the HRQL evolution over 5 years for 1,000 patients initiating a protease inhibitor (PI)-containing therapy, using MOS SF-36 physical (PCS) and mental (MCS) scores. In parallel with a classical separate random effects model, we used a joint parameter-dependent selection model to account for non-ignorable dropout.
RESULTS: HRQL evolved according to a two-phase pattern, characterized by an initial improvement during the year following HAART initiation and a relative stabilization thereafter. Immunodepression and self-reported side effects were found to be negative predictors of both PCS and MCS scores. Hepatitis C virus coinfection and AIDS clinical stage were found to affect physical HRQL. Results were not significantly altered when accounting for dropout.
CONCLUSION: Such results, obtained on a large sample of HIV-infected patients with extensive follow-up, underline the need for a regular monitoring of patients' immunological status and for a better management of their experience with hepatitis C and HAART.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID17268929
  
Advertise on this site.